Citations (102)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Paul Arras, Han Byul Yoo, Lukas Pekar, Christian Schröter, Thomas Clarke, Simon Krah, Daniel Klewinghaus, Vanessa Siegmund, Andreas Evers & Stefan Zielonka. (2023) A library approach for the de novo high-throughput isolation of humanized VHH domains with favorable developability properties following camelid immunization. mAbs 15:1.
Read now
Read now
Hanine Rafidi, Sharmila Rajan, Konnie Urban, Whitney Shatz-Binder, Keliana Hui, Gregory Z. Ferl, Amrita V. Kamath & C. Andrew Boswell. (2022) Effect of molecular size on interstitial pharmacokinetics and tissue catabolism of antibodies. mAbs 14:1.
Read now
Read now
Mahendra P. Deonarain & Gokhan Yahioglu. (2021) Current strategies for the discovery and bioconjugation of smaller, targetable drug conjugates tailored for solid tumor therapy. Expert Opinion on Drug Discovery 16:6, pages 613-624.
Read now
Read now
Lukas Pekar, Michael Busch, Bernhard Valldorf, Steffen C. Hinz, Lars Toleikis, Simon Krah & Stefan Zielonka. (2020) Biophysical and biochemical characterization of a VHH-based IgG-like bi- and trispecific antibody platform. mAbs 12:1.
Read now
Read now
Hsueh-Yuan Chang, Kasey Morrow, Emily Bonacquisti, WanYing Zhang & Dhaval K. Shah. (2018) Antibody pharmacokinetics in rat brain determined using microdialysis. mAbs 10:6, pages 843-853.
Read now
Read now
Matthias Vandesquille, Tengfei Li, Chrystelle Po, Christelle Ganneau, Pascal Lenormand, Clémence Dudeffant, Christian Czech, Fiona Grueninger, Charles Duyckaerts, Benoît Delatour, Marc Dhenain, Pierre Lafaye & Sylvie Bay. (2017) Chemically-defined camelid antibody bioconjugate for the magnetic resonance imaging of Alzheimer's disease. mAbs 9:6, pages 1016-1027.
Read now
Read now
Timothy J. Egan, Dania Diem, Richard Weldon, Tessa Neumann, Sebastian Meyer & David M. Urech. (2017) Novel multispecific heterodimeric antibody format allowing modular assembly of variable domain fragments. mAbs 9:1, pages 68-84.
Read now
Read now
Articles from other publishers (95)
Arman Hosseini, Sachin Kumar, Kyle Hedin & Maryam Raeeszadeh‐Sarmazdeh. (2023)
Engineering minimal tissue inhibitors of metalloproteinase targeting
MMPs
via gene shuffling and yeast surface display
. Protein Science 32:12.
Crossref
Crossref
Sharad Sharma, Antony Leonard, Kathryn Phoenix, Hsueh Yuan Chang, Jun Wang & Steven Hansel. (2023) Systemically Administered Anti-uPAR Antibody Plasma and Lung ELF Pharmacokinetics Characterized by Minimal Lung PBPK Model. AAPS PharmSciTech 24:8.
Crossref
Crossref
Christelle Remy, Elodie Pintado, Marshall Dunlop, Shirley Schön, Patricia Kleinpeter, Homa Rozanes, Laetitia Fend, Renée Brandely, Michel Geist, Delphine Suhner, Eline Winter, Nathalie Silvestre, Claire Huguet, Peter Fitzgerald, Eric Quéméneur & Jean-Baptiste Marchand. (2023) Design and selection of anti-PD-L1 single-domain antibody and tumor necrosis factor superfamily ligands for an optimal vectorization in an oncolytic virus. Frontiers in Bioengineering and Biotechnology 11.
Crossref
Crossref
Simon Huet, Magali Zeisser Labouebe, Rute Castro, Perrine Jacquot, Jessy Pedrault, Sébastien Viollet, Gaetan Van Simaeys, Gilles Doumont, Lionel Larbanoix, Egor Zindy, António E. Cunha, Leonardo Scapozza & Mathieu Cinier. (2023) Targeted Nanofitin-drug Conjugates Achieve Efficient Tumor Delivery and Therapeutic Effect in an EGFRpos Mouse Xenograft Model. Molecular Cancer Therapeutics 22:11, pages 1343-1351.
Crossref
Crossref
Chuan-Chuan Huang, Hsiang-Hsuan Sung, Hsiu-Chuan Li, Shi-Chuen Miaw, John T. Kung, Min-Yuan Chou & Betty A. Wu-Hsieh. (2023) A novel trivalent non-Fc anti-CD3 Collabody preferentially induces Th1 cell apoptosis in vitro and long-lasting remission in recent-onset diabetic NOD mice. Frontiers in Immunology 14.
Crossref
Crossref
Pakpoom Navanukraw, Sroisuda Chotimanukul, Taratorn Kemthong, Kiattawee Choowongkomon & Kaywalee Chatdarong. (2023) Impaired Testicular Function without Altering Testosterone Concentration Using an Anti-Follicular-Stimulating Hormone Receptor (Anti-FSHr) Single-Chain Variable Fragment (scFv) in Long-Tailed Macaques (Macaca fascicularis). Animals 13:14, pages 2282.
Crossref
Crossref
Linghui Qian, Xuefen Lin, Xue Gao, Rizwan Ullah Khan, Jia-Yu Liao, Shubo Du, Jingyan Ge, Su Zeng & Shao Q. Yao. (2023) The Dawn of a New Era: Targeting the “Undruggables” with Antibody-Based Therapeutics. Chemical Reviews 123:12, pages 7782-7853.
Crossref
Crossref
Anthony Marchand, Lucia Bonati, Sailan Shui, Leo Scheller, Pablo Gainza, Stéphane Rosset, Sandrine Georgeon, Li Tang & Bruno E. Correia. (2023) Rational Design of Chemically Controlled Antibodies and Protein Therapeutics. ACS Chemical Biology 18:6, pages 1259-1265.
Crossref
Crossref
Cynthia Rodríguez-Nava, Carlos Ortuño-Pineda, Berenice Illades-Aguiar, Eugenia Flores-Alfaro, Marco Antonio Leyva-Vázquez, Isela Parra-Rojas, Oscar del Moral-Hernández, Amalia Vences-Velázquez, Karen Cortés-Sarabia & Luz del Carmen Alarcón-Romero. (2023) Mechanisms of Action and Limitations of Monoclonal Antibodies and Single Chain Fragment Variable (scFv) in the Treatment of Cancer. Biomedicines 11:6, pages 1610.
Crossref
Crossref
Philipp Knopf, Dimitri Stowbur, Sabrina H. L. Hoffmann, Marieke F. Fransen, Johannes Schwenck, Bernd J. Pichler & Manfred Kneilling. (2023) Preclinical Identification Of Tumor-Draining Lymph Nodes Using a Multimodal Non-invasive In vivo Imaging Approach. Molecular Imaging and Biology 25:3, pages 606-618.
Crossref
Crossref
David Flowers, David Bassen, Georgi I. Kapitanov, Diana Marcantonio, John M. Burke, Joshua F. Apgar, Alison Betts & Fei Hua. (2023) A next generation mathematical model for the in vitro to clinical translation of T-cell engagers. Journal of Pharmacokinetics and Pharmacodynamics 50:3, pages 215-227.
Crossref
Crossref
Shrayasee Saha, Amanda Sparkes, Esther I. Matus, Peter Lee & Jean Gariépy. (2023) The IgV domain of the poliovirus receptor alone is immunosuppressive and binds to its receptors with comparable affinity. Scientific Reports 13:1.
Crossref
Crossref
Elliot Offman, Noopur Singh, Mark W. Julian, Landon W. Locke, Sabahattin Bicer, Jonah Mitchell, Thomas Matthews, Kirsten Anderson & Elliott D. Crouser. (2023) Leveraging in vitro and pharmacokinetic models to support bench to bedside investigation of XTMAB-16 as a novel pulmonary sarcoidosis treatment. Frontiers in Pharmacology 14.
Crossref
Crossref
Reena Gupta, Jitendra Gupta & Abhishek Pathak. (2023) Immunoliposomes: A Targeted Drug Delivery System for Cancer
Therapeutics and Vaccination. Current Pharmaceutical Biotechnology 24:3, pages 366-390.
Crossref
Crossref
Yong Wang, Jingming Zhang, Boyang Han, Linzhi Tan, Wenkang Cai, Yuxuan Li, Yeyu Su, Yutong Yu, Xin Wang, Xiaojiang Duan, Haoyu Wang, Xiaomeng Shi, Jing Wang, Xing Yang & Tao Liu. (2023) Noncanonical amino acids as doubly bio-orthogonal handles for one-pot preparation of protein multiconjugates. Nature Communications 14:1.
Crossref
Crossref
Sacha Zinn, Rodrigo Vazquez-Lombardi, Carsten Zimmermann, Puja Sapra, Lutz Jermutus & Daniel Christ. (2023) Advances in antibody-based therapy in oncology. Nature Cancer 4:2, pages 165-180.
Crossref
Crossref
Paul M. O'Byrne, Reynold A. PanettieriJr.Jr., Christian Taube, Caterina Brindicci, Margaret Fleming & Pablo Altman. (2023) Development of an inhaled anti-TSLP therapy for asthma. Pulmonary Pharmacology & Therapeutics 78, pages 102184.
Crossref
Crossref
Etsuji Kaneko. (2023) Development in Antibody-based Drug Delivery System Technology抗体を活用したドラッグデリバリー技術の開発状況. Drug Delivery System 38:1, pages 49-57.
Crossref
Crossref
Rico Ballmann, Kai-Thomas Schneider, Kristian Daniel Ralph Roth & Stefan Dübel. 2023. Phage Display. Phage Display
411
417
.
Harald Kolmar, Julius Grzeschik, Doreen Könning, Simon Krah & Stefan Zielonka. 2023. Phage Display. Phage Display
227
243
.
Hossein Salimi-Moosavi & Marcus Soto. (2022) A Non-radiometric Approach to Determine Tissue Vascular Blood Volume in Biodistribution Studies. The AAPS Journal 24:6.
Crossref
Crossref
Luigi Liguori, Giovanna Polcaro, Annunziata Nigro, Valeria Conti, Carmine Sellitto, Francesco Perri, Alessandro Ottaiano, Marco Cascella, Pio Zeppa, Alessandro Caputo, Stefano Pepe & Francesco Sabbatino. (2022) Bispecific Antibodies: A Novel Approach for the Treatment of Solid Tumors. Pharmaceutics 14:11, pages 2442.
Crossref
Crossref
Rohit Sharma, Shishu K. Suman & Archana Mukherjee. (2022) Antibody-based Radiopharmaceuticals as Theranostic Agents: An
Overview. Current Medicinal Chemistry 29:38, pages 5979-6005.
Crossref
Crossref
Myriam Belén González Viacava, Carlos Leónidas Leiva, María Eugenia Tavarone, José Christian Dokmetjian, Osvaldo Cascone, Pablo Chacana & Matías Fingermann. (2022) A simple and economic three-step process for producing highly purified Fab’ fragments directly from the egg yolk water-soluble fraction. Journal of Chromatography B, pages 123486.
Crossref
Crossref
Beibei Meng, Stephan L. Grage, Oleg Babii, Masanari Takamiya, Neil MacKinnon, Tim Schober, Illia Hutskalov, Omar Nassar, Sergii Afonin, Serhii Koniev, Igor V. Komarov, Jan G. Korvink, Uwe Strähle & Anne S. Ulrich. (2022)
Highly Fluorinated Peptide Probes with Enhanced In Vivo Stability for
19
F‐MRI
. Small 18:41.
Crossref
Crossref
Julie S. Moyers, Ryan J. Hansen, Jonathan W. Day, Craig D. Dickinson, Chen Zhang, Xiaoping Ruan, Liyun Ding, Robin M. Brown, Hana E. Baker & John M. Beals. (2022) Preclinical Characterization of LY3209590, a Novel Weekly Basal Insulin Fc-Fusion Protein. Journal of Pharmacology and Experimental Therapeutics 382:3, pages 346-355.
Crossref
Crossref
Hantao Lou & Xuetao Cao. (2022) Antibody variable region engineering for improving cancer immunotherapy. Cancer Communications 42:9, pages 804-827.
Crossref
Crossref
Xin Gan, Qianqian Shan, He Li, Rick Janssens, Yuqiang Shen, Yun He, Fei Chen, Rien van Haperen, Dubravka Drabek, Jin Li, Yang Zhang, Jiuqiao Zhao, Beibei Qin, Ming-Jin Jheng, Victor Chen, Jingsong Wang, Yiping Rong & Frank Grosveld. (2022)
An anti-CTLA-4 heavy chain–only antibody with enhanced T
reg
depletion shows excellent preclinical efficacy and safety profile
. Proceedings of the National Academy of Sciences 119:32.
Crossref
Crossref
Yang Wang, Wenjie Yuan, Siqi Guo, Qiqi Li, Xiaomei Chen, Cheng Li, Qianying Liu, Lei Sun, Zhenguo Chen, Zhenghong Yuan, Cheng Luo, Shijie Chen, Shuping Tong, Michael Nassal, Yu-Mei Wen & Yong-Xiang Wang. (2022) A 33-residue peptide tag increases solubility and stability of Escherichia coli produced single-chain antibody fragments. Nature Communications 13:1.
Crossref
Crossref
Yanling Wu, Quanxiao Li, Yu Kong, Zhi Wang, Cheng Lei, Ji Li, Lulu Ding, Chunyu Wang, Yaping Cheng, Yaozhu Wei, Yuanlin Song, Zhenlin Yang, Chao Tu, Yu Ding & Tianlei Ying. (2022) A highly stable human single-domain antibody-drug conjugate exhibits superior penetration and treatment of solid tumors. Molecular Therapy 30:8, pages 2785-2799.
Crossref
Crossref
Natalie M. Morris, Johanna A. Blee & Sabine Hauert. (2022) Developing a computational pharmacokinetic model of systemic snakebite envenomation and antivenom treatment. Toxicon 215, pages 77-90.
Crossref
Crossref
Kathryn Ball, Gerard Bruin, Enrique Escandón, Christoph Funk, Joao N.S. Pereira, Tong-Yuan Yang & Hongbin Yu. (2022) Characterizing the Pharmacokinetics and Biodistribution of Therapeutic Proteins: An Industry White Paper. Drug Metabolism and Disposition 50:6, pages 858-866.
Crossref
Crossref
Yasuaki Anami, Yoshihiro Otani, Wei Xiong, Summer Y.Y. Ha, Aiko Yamaguchi, Kimberly A. Rivera-Caraballo, Ningyan Zhang, Zhiqiang An, Balveen Kaur & Kyoji Tsuchikama. (2022) Homogeneity of antibody-drug conjugates critically impacts the therapeutic efficacy in brain tumors. Cell Reports 39:8, pages 110839.
Crossref
Crossref
Nils Rouven Hansmeier, Ina Sophie Büschlen, Rose Yinghan Behncke, Sascha Ulferts, Radjesh Bisoendial & René Hägerling. (2022) 3D Visualization of Human Blood Vascular Networks Using Single-Domain Antibodies Directed against Endothelial Cell-Selective Adhesion Molecule (ESAM). International Journal of Molecular Sciences 23:8, pages 4369.
Crossref
Crossref
Merve Arslan, Murat Karadag, Ebru Onal, Emine Gelinci, Gulcin Cakan-Akdogan & Sibel Kalyoncu. (2022) Effect of non-repetitive linker on in vitro and in vivo properties of an anti-VEGF scFv. Scientific Reports 12:1.
Crossref
Crossref
Margherita Passariello, Asami Yoshioka, Kota Takahashi, Shu-ichi Hashimoto, Rosa Rapuano Lembo, Lorenzo Manna, Koji Nakamura & Claudia De Lorenzo. (2022) Novel Bi-Specific Immuno-Modulatory Tribodies Potentiate T Cell Activation and Increase Anti-Tumor Efficacy. International Journal of Molecular Sciences 23:7, pages 3466.
Crossref
Crossref
Sami El Khatib & Mohamed Salla. (2022) The mosaic puzzle of the therapeutic monoclonal antibodies and antibody fragments - A modular transition from full-length immunoglobulins to antibody mimetics. Leukemia Research Reports 18, pages 100335.
Crossref
Crossref
Daniela Bumbaca Yadav, Kapil Gadkar & Isabel Figueroa. 2022. Haschek and Rousseaux's Handbook of Toxicologic Pathology. Haschek and Rousseaux's Handbook of Toxicologic Pathology
77
100
.
David Bussing, Zhe Li, Yingyi Li, Hsuan-Ping Chang, Hsueh-Yuan Chang, Leiming Guo, Ashwni Verma & Dhaval K. Shah. (2021) Pharmacokinetics of Monoclonal Antibody and Antibody Fragments in the Mouse Eye Following Systemic Administration. The AAPS Journal 23:6.
Crossref
Crossref
Zhe Li, Yingyi Li, Hsuan Ping Chang, Xiaoying Yu & Dhaval K. Shah. (2021) Two-pore physiologically based pharmacokinetic model validation using whole-body biodistribution of trastuzumab and different-size fragments in mice. Journal of Pharmacokinetics and Pharmacodynamics 48:5, pages 743-762.
Crossref
Crossref
Nathan P. Crilly & Monica R. Mugnier. (2021) Thinking outside the blood: Perspectives on tissue-resident Trypanosoma brucei. PLOS Pathogens 17:9, pages e1009866.
Crossref
Crossref
Gabriele Antonarelli, Federica Giugliano, Chiara Corti, Matteo Repetto, Paolo Tarantino & Giuseppe Curigliano. (2021) Research and Clinical Landscape of Bispecific Antibodies for the Treatment of Solid Malignancies. Pharmaceuticals 14:9, pages 884.
Crossref
Crossref
David Leung, Samuel Bonacorsi, Ralph Adam Smith, Wolfgang Weber & Wendy Hayes. (2021) Molecular Imaging and the PD-L1 Pathway: From Bench to Clinic. Frontiers in Oncology 11.
Crossref
Crossref
Denise Heise, Alicia Derrac SoriaSelina Hansen, Christine Dambietz, Mohammad AkbarzadehAnna F. Berg, Georg H. Waetzig, Simon A. Jones, Radovan DvorskyMohammad R. AhmadianJürgen Scheller & Jens M. Moll. (2021)
Selective inhibition of IL-6 trans-signaling by a miniaturized, optimized chimeric soluble gp130 inhibits T
H
17 cell expansion
. Science Signaling 14:696.
Crossref
Crossref
Anne di Tommaso, Matthieu O Juste, Zineb Lakhrif, Marie-Noëlle Mévélec, Coraline Borowczyk, Pierre Hammeni, Guillaume Désoubeaux, Nathalie Van Langendonck, Françoise Debierre-Grockiego, Nicolas Aubrey & Isabelle Dimier-Poisson. (2021) Engineering and Functional Evaluation of Neutralizing Antibody Fragments Against Congenital Toxoplasmosis. The Journal of Infectious Diseases 224:4, pages 705-714.
Crossref
Crossref
Andrew T. Lucas, Amber Moody, Allison N. Schorzman & William C. Zamboni. (2021) Importance and Considerations of Antibody Engineering in Antibody-Drug Conjugates Development from a Clinical Pharmacologist’s Perspective. Antibodies 10:3, pages 30.
Crossref
Crossref
Lin Zhang, Zewei Wang, Zhiyuan Wang, Fang Luo, Mingfeng Guan, Meimei Xu, Yundong Li, Yaoyang Zhang, Zhaoyin Wang & Wenyuan Wang. (2021) A Simple and Efficient Method to Generate Dual Site-Specific Conjugation ADCs with Cysteine Residue and an Unnatural Amino Acid. Bioconjugate Chemistry 32:6, pages 1094-1104.
Crossref
Crossref
Mariam Elshiaty, Hannah Schindler & Petros Christopoulos. (2021) Principles and Current Clinical Landscape of Multispecific Antibodies against Cancer. International Journal of Molecular Sciences 22:11, pages 5632.
Crossref
Crossref
Philipp Wolf, Georgina Gavins, Annette G. Beck‐Sickinger & Oliver Seitz. (2021) Strategies for Site‐Specific Labeling of Receptor Proteins on the Surfaces of Living Cells by Using Genetically Encoded Peptide Tags. ChemBioChem 22:10, pages 1717-1732.
Crossref
Crossref
Amy A. Lo, Jennifer Johnston, Ji Li, Danielle Mandikian, Maria Hristopoulos, Robyn Clark, Dorothee Nickles, Wei-Ching Liang, Kathy Hötzel, Debra Dunlap, Thinh Pham, Hao Cai, Meric Ovacik, Daniel Bravo-Perez, Elaine Mai, Dionysos Slaga, Diego Ellerman, James Ziai, Klara Totpal, Genee Lee, C. Andrew Boswell, Jian Payandeh, Yan Wu & Teemu T. Junttila. (2021) Anti-LYPD1/CD3 T-Cell-Dependent Bispecific Antibody for the Treatment of Ovarian Cancer. Molecular Cancer Therapeutics 20:4, pages 716-725.
Crossref
Crossref
Yu Tang & Yanguang Cao. (2021) Modeling Pharmacokinetics and Pharmacodynamics of Therapeutic Antibodies: Progress, Challenges, and Future Directions. Pharmaceutics 13:3, pages 422.
Crossref
Crossref
Hiroyasu Muramatsu, Taichi Kuramochi, Hitoshi Katada, Atsunori Ueyama, Yoshinao Ruike, Ken Ohmine, Meiri Shida-Kawazoe, Rie Miyano-Nishizawa, Yuichiro Shimizu, Momoko Okuda, Yuji Hori, Madoka Hayashi, Kenta Haraya, Nobuhiro Ban, Tatsuya Nonaka, Masaki Honda, Hidetomo Kitamura, Kunihiro Hattori, Takehisa Kitazawa, Tomoyuki Igawa, Yoshiki Kawabe & Junichi Nezu. (2021) Novel myostatin-specific antibody enhances muscle strength in muscle disease models. Scientific Reports 11:1.
Crossref
Crossref
Emma von Witting, Sarah Lindbo, Magnus Lundqvist, Marit Möller, Andreas Wisniewski, Sara Kanje, Johan Rockberg, Hanna Tegel, Mikael Åstrand, Mathias Uhlén & Sophia Hober. (2020) Small Bispecific Affinity Proteins for Simultaneous Target Binding and Albumin-Associated Half-Life Extension. Molecular Pharmaceutics 18:1, pages 328-337.
Crossref
Crossref
Doreen Koenning & Jonas V. Schaefer. 2021. Introduction to Antibody Engineering. Introduction to Antibody Engineering
215
249
.
Jens König, Michael Hust & Joop van den Heuvel. 2021. Multiprotein Complexes. Multiprotein Complexes
59
76
.
Tianqi Xu, Haozhong Ding, Anzhelika Vorobyeva, Maryam Oroujeni, Anna Orlova, Vladimir Tolmachev & Torbjörn Gräslund. (2020) Drug Conjugates Based on a Monovalent Affibody Targeting Vector Can Efficiently Eradicate HER2 Positive Human Tumors in an Experimental Mouse Model. Cancers 13:1, pages 85.
Crossref
Crossref
Mahendra P Deonarain & Quinn Xue. (2020) Tackling solid tumour therapy with small-format drug conjugates. Antibody Therapeutics 3:4, pages 237-245.
Crossref
Crossref
Daniel Bergman, Camilla Bäckström, Helene Hansson-Hamlin, Anders Larsson & Bodil Ström Holst. (2020) Pre-existing canine anti-IgG antibodies: implications for immunotherapy, immunogenicity testing and immunoassay analysis. Scientific Reports 10:1.
Crossref
Crossref
Hao Cai, Victor Yip, M. Violet Lee, Sylvia Wong, Ola Saad, Shuguang Ma, Nina Ljumanovic, S. Cyrus Khojasteh, Amrita V. Kamath & Ben-Quan Shen. (2020)
Characterization of Tissue Distribution, Catabolism, and Elimination of an Anti–
Staphylococcus aureus
THIOMAB Antibody-Antibiotic Conjugate in Rats
. Drug Metabolism and Disposition 48:11, pages 1161-1168.
Crossref
Crossref
Mélanie Demeules, Allan Scarpitta, Catalina Abad, Henri Gondé, Romain Hardet, Carolina Pinto-Espinoza, Anna Marei Eichhoff, Waldemar Schäfer, Friedrich Haag, Friedrich Koch-Nolte & Sahil Adriouch. (2020) Evaluation of P2X7 Receptor Function in Tumor Contexts Using rAAV Vector and Nanobodies (AAVnano). Frontiers in Oncology 10.
Crossref
Crossref
Laurence Gauzy-Lazo, Ingrid Sassoon & Marie-Priscille Brun. (2020) Advances in Antibody–Drug Conjugate Design: Current Clinical Landscape and Future Innovations. SLAS Discovery 25:8, pages 843-868.
Crossref
Crossref
Kip P. Conner, Siva Charan Devanaboyina, Veena A. Thomas & Dan A. Rock. (2020) The biodistribution of therapeutic proteins: Mechanism, implications for pharmacokinetics, and methods of evaluation. Pharmacology & Therapeutics 212, pages 107574.
Crossref
Crossref
Gavin Bennett, Amy Brown, Gemma Mudd, Philip Huxley, Katerine Van Rietschoten, Silvia Pavan, Liuhong Chen, Sophie Watcham, Johanna Lahdenranta & Nicholas Keen. (2020)
MMAE Delivery Using the
Bicycle
Toxin Conjugate BT5528
. Molecular Cancer Therapeutics 19:7, pages 1385-1394.
Crossref
Crossref
Romany Abskharon, Paul M. Seidler, Michael R. Sawaya, Duilio Cascio, Tianxiao P. Yang, Stephan Philipp, Christopher Kazu Williams, Kathy L. Newell, Bernardino Ghetti, Michael A. DeTure, Dennis W. Dickson, Harry V. Vinters, Philip L. Felgner, Rie Nakajima, Charles G. Glabe & David S. Eisenberg. (2020) Crystal structure of a conformational antibody that binds tau oligomers and inhibits pathological seeding by extracts from donors with Alzheimer's disease. Journal of Biological Chemistry 295:31, pages 10662-10676.
Crossref
Crossref
Zachary R. Crook, Emily Girard, Gregory P. Sevilla, Morgan Merrill, Della Friend, Peter B. Rupert, Fiona Pakiam, Elizabeth Nguyen, Chunfeng Yin, Raymond O. Ruff, Gene Hopping, Andrew D. Strand, Kathryn A.K. Finton, Margo Coxon, Andrew J. Mhyre, Roland K. Strong & James M. Olson. (2020) A TfR-Binding Cystine-Dense Peptide Promotes Blood–Brain Barrier Penetration of Bioactive Molecules. Journal of Molecular Biology.
Crossref
Crossref
Palapuravan Anees & Marc A. Gauthier. (2019) Homogenous Scavenging Resolves Low-Purification Yield/Selectivity Caused by Secondary Binding of Protein-A to Antigen-Binding Antibody Fragments. Biomacromolecules 21:2, pages 825-829.
Crossref
Crossref
Pieterjan Debie, Chrystel Lafont, Michel Defrise, Inge Hansen, Danny M. van Willigen, Fijs W.B. van Leeuwen, Rik Gijsbers, Matthias D'Huyvetter, Nick Devoogdt, Tony Lahoutte, Patrice Mollard & Sophie Hernot. (2020) Size and affinity kinetics of nanobodies influence targeting and penetration of solid tumours. Journal of Controlled Release 317, pages 34-42.
Crossref
Crossref
L. Nathan Tumey. 2020. Antibody-Drug Conjugates. Antibody-Drug Conjugates
1
22
.
Zachary R. Crook, Gregory P. Sevilla, Andrew J. Mhyre & James M. Olson. 2020. Genotype Phenotype Coupling. Genotype Phenotype Coupling
363
396
.
Yvonne W.S. Jauw, Joseph A. O’Donoghue, Josée M. Zijlstra, Otto S. Hoekstra, C. Willemien Menke-van der Houven van Oordt, Franck Morschhauser, Jorge A. Carrasquillo, Sonja Zweegman, Neeta Pandit-Taskar, Adriaan A. Lammertsma, Guus. A.M.S. van Dongen, Ronald Boellaard, Wolfgang A. Weber & Marc C. Huisman. (2019)
89
Zr-Immuno-PET: Toward a Noninvasive Clinical Tool to Measure Target Engagement of Therapeutic Antibodies In Vivo
. Journal of Nuclear Medicine 60:12, pages 1825-1832.
Crossref
Crossref
Alberto Dal Corso, Luca Pignataro, Laura Belvisi & Cesare Gennari. (2019) Innovative Linker Strategies for Tumor‐Targeted Drug Conjugates. Chemistry – A European Journal 25:65, pages 14740-14757.
Crossref
Crossref
Juha Punnonen, David Rosen, Luis Zuniga, Kennett Sprogøe & Mohammad Tabrizi. (2019) Cytokine Therapeutics in Cancer Immunotherapy: Design and Development. Current Pharmacology Reports 5:5, pages 377-390.
Crossref
Crossref
Steven Coats, Marna Williams, Benjamin Kebble, Rakesh Dixit, Leo Tseng, Nai-Shun Yao, David A. Tice & Jean-Charles Soria. (2019) Antibody–Drug Conjugates: Future Directions in Clinical and Translational Strategies to Improve the Therapeutic Index. Clinical Cancer Research 25:18, pages 5441-5448.
Crossref
Crossref
Adva Mechaly, Uri Elia, Ron Alcalay, Hila Cohen, Eyal Epstein, Ofer Cohen & Ohad Mazor. (2019) Inhibition of Francisella tularensis phagocytosis using a novel anti-LPS scFv antibody fragment. Scientific Reports 9:1.
Crossref
Crossref
Zhe Li & Dhaval K. Shah. (2019) Two-pore physiologically based pharmacokinetic model with de novo derived parameters for predicting plasma PK of different size protein therapeutics. Journal of Pharmacokinetics and Pharmacodynamics 46:3, pages 305-318.
Crossref
Crossref
Pieterjan Debie & Sophie Hernot. (2019) Emerging Fluorescent Molecular Tracers to Guide Intra-Operative Surgical Decision-Making. Frontiers in Pharmacology 10.
Crossref
Crossref
Adam Bates & Christine A. Power. (2019) David vs. Goliath: The Structure, Function, and Clinical Prospects of Antibody Fragments. Antibodies 8:2, pages 28.
Crossref
Crossref
Kasandra Bélanger, Umar Iqbal, Jamshid Tanha, Roger MacKenzie, Maria Moreno & Danica Stanimirovic. (2019) Single-Domain Antibodies as Therapeutic and Imaging Agents for the Treatment of CNS Diseases. Antibodies 8:2, pages 27.
Crossref
Crossref
Honghui Zhou & Diane R. MouldXi Chen & Weirong Wang. 2019. Quantitative Pharmacology and Individualized Therapy Strategies in Development of Therapeutic Proteins for Immune‐Mediated Inflammatory Diseases. Quantitative Pharmacology and Individualized Therapy Strategies in Development of Therapeutic Proteins for Immune‐Mediated Inflammatory Diseases
43
64
.
Antari Khot, Satoko Matsueda, Veena A. Thomas, Richard C. Koya & Dhaval K. Shah. (2019) Measurement and Quantitative Characterization of Whole-Body Pharmacokinetics of Exogenously Administered T Cells in Mice. Journal of Pharmacology and Experimental Therapeutics 368:3, pages 503-513.
Crossref
Crossref
Patrick M. Glassman & Joseph P. Balthasar. (2019) Physiologically-based modeling of monoclonal antibody pharmacokinetics in drug discovery and development. Drug Metabolism and Pharmacokinetics 34:1, pages 3-13.
Crossref
Crossref
Cheng Li, Yang Wang, Tiantian Liu, Matthias Niklasch, Ke Qiao, Sarah Durand, Li Chen, Mifang Liang, Thomas F. Baumert, Shuping Tong, Michael Nassal, Yu-Mei Wen & Yong-Xiang Wang. (2019) An E. coli-produced single-chain variable fragment (scFv) targeting hepatitis B virus surface protein potently inhibited virion secretion. Antiviral Research 162, pages 118-129.
Crossref
Crossref
Timothy Jenkins, Thomas Fryer, Rasmus Dehli, Jonas Jürgensen, Albert Fuglsang-Madsen, Sofie Føns & Andreas Laustsen. (2019) Toxin Neutralization Using Alternative Binding Proteins. Toxins 11:1, pages 53.
Crossref
Crossref
Gorawit Yusakul, Seiichi Sakamoto, Hiroyuki Tanaka & Satoshi Morimoto. (2018) Improvement of heavy and light chain assembly by modification of heavy chain constant region 1 (CH1): Application for the construction of an anti-paclitaxel fragment antigen-binding (Fab) antibody. Journal of Biotechnology 288, pages 41-47.
Crossref
Crossref
Mahendra P. Deonarain. (2018) Miniaturised ‘antibody’-drug conjugates for solid tumours?. Drug Discovery Today: Technologies 30, pages 47-53.
Crossref
Crossref
Chuan Shi, Shalom Goldberg, Tricia Lin, Vadim Dudkin, Wayne Widdison, Luke Harris, Sharon Wilhelm, Yazen Jmeian, Darryl Davis, Karyn O'Neil, Naidong Weng & Wenying Jian. (2018) Bioanalytical workflow for novel scaffold protein–drug conjugates: quantitation of total Centyrin protein, conjugated Centyrin and free payload for Centyrin–drug conjugate in plasma and tissue samples using liquid chromatography–tandem mass spectrometry. Bioanalysis 10:20, pages 1651-1665.
Crossref
Crossref
Daniel Lightwood, Markus Tservistas, Monique Zehentleitner, Kaushik Sarkar, Alison Turner, Marguerite Bracher, Bryan Smith, Sabrina Lamour, Tim Bourne, Stevan Shaw, Neil Gozzard & Roger T. Palframan. (2018) Efficacy of an Inhaled IL-13 Antibody Fragment in a Model of Chronic Asthma. American Journal of Respiratory and Critical Care Medicine 198:5, pages 610-619.
Crossref
Crossref
Mahendra Deonarain, Gokhan Yahioglu, Ioanna Stamati, Anja Pomowski, James Clarke, Bryan Edwards, Soraya Diez-Posada & Ashleigh Stewart. (2018) Small-Format Drug Conjugates: A Viable Alternative to ADCs for Solid Tumours?. Antibodies 7:2, pages 16.
Crossref
Crossref
Abbas Alibakhshi, Fatemeh Abarghooi Kahaki, Shahrzad Ahangarzadeh, Hajar Yaghoobi, Fatemeh Yarian, Roghaye Arezumand, Javad Ranjbari, Ahad Mokhtarzadeh & Miguel de la Guardia. (2017) Targeted cancer therapy through antibody fragments-decorated nanomedicines. Journal of Controlled Release 268, pages 323-334.
Crossref
Crossref
Zhe Li, Ben-Fillippo Krippendorff & Dhaval K. Shah. (2017) Influence of Molecular size on the clearance of antibody fragments. Pharmaceutical Research 34:10, pages 2131-2141.
Crossref
Crossref
Tengfei Li, Matthias Vandesquille, Fani Koukouli, Clémence Dudeffant, Ihsen Youssef, Pascal Lenormand, Christelle Ganneau, Uwe Maskos, Christian Czech, Fiona Grueninger, Charles Duyckaerts, Marc Dhenain, Sylvie Bay, Benoît Delatour & Pierre Lafaye. (2016) Camelid single-domain antibodies: A versatile tool for in vivo imaging of extracellular and intracellular brain targets. Journal of Controlled Release 243, pages 1-10.
Crossref
Crossref
Eric L. Schneider, Brian R. Hearn, Samuel J. Pfaff, Shaun D. Fontaine, Ralph Reid, Gary W. Ashley, Stefanie Grabulovski, Verena Strassberger, Lorenz Vogt, Thomas Jung & Daniel V. Santi. (2016) Approach for Half-Life Extension of Small Antibody Fragments That Does Not Affect Tissue Uptake. Bioconjugate Chemistry 27:10, pages 2534-2539.
Crossref
Crossref
Cornelius Cilliers, Hans Guo, Jianshan Liao, Nikolas Christodolu & Greg M. Thurber. (2016) Multiscale Modeling of Antibody-Drug Conjugates: Connecting Tissue and Cellular Distribution to Whole Animal Pharmacokinetics and Potential Implications for Efficacy. The AAPS Journal 18:5, pages 1117-1130.
Crossref
Crossref
Alison Smith, Hugh Manoli, Stacey Jaw, Kimberley Frutoz, Alan L. Epstein, Leslie A. Khawli & Frank-Peter Theil. (2016) Unraveling the Effect of Immunogenicity on the PK/PD, Efficacy, and Safety of Therapeutic Proteins. Journal of Immunology Research 2016, pages 1-9.
Crossref
Crossref
Myriam Belén González Viacava, Carlos Leónidas Leiva, María Eugenia Tavarone, José Christian Dokmetjian, Osvaldo Cascone, Pablo Chacana & Matias Fingermann. (2022) Simple and Economic Three-Step Process for Producing Highly Purified Fab’ Fragments Directly from the Egg Yolk Water-Soluble Fraction. SSRN Electronic Journal.
Crossref
Crossref